Skip to main content
Terug
KSRBF logo

Kossan Rubber Industries Bhd

Datakwaliteit: 100%
Overbought
KSRBF
OTC Healthcare Medical - Instruments & Supplies
€ 0,33
€ 0,00 (0,00%)
Marktkapitalisatie: 841,70M
Dagbereik
€ 0,33 € 0,33
52-Weeksbereik
€ 0,27 € 0,33
Volume
1.000
50D / 200D Gem.
€ 0,33 / € 0,32
Vorige Slotkoers
€ 0,33

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E 5,6 0,4
P/B 0,2 2,9
ROE % 4,1 3,7
Net Margin % 8,7 3,8
Rev Growth 5Y % -28,4 10,0
D/E 0,0 0,2

Belangrijkste Punten

Revenue declined -28,39% annually over 5 years
Earnings grew 27,58% over the past year
ROE of 4,11% is below average
Debt/Equity of 0,02 — conservative balance sheet
Generating 51,75M in free cash flow
P/E of 5,58 — trading at a low valuation

Groei

Revenue Growth (5Y)
-28,39%
Revenue (1Y)-8,53%
Earnings (1Y)27,58%
FCF Growth (3Y)-33,10%

Kwaliteit

Return on Equity
4,11%
ROIC2,63%
Net Margin8,66%
Op. Margin7,55%

Veiligheid

Debt / Equity
0,02
Current Ratio9,80
Interest Coverage94,74

Waardering

P/E Ratio
5,58
P/B Ratio0,23
EV/EBITDA-0,11
Dividend Yield0,01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -8,53% Revenue Growth (3Y) 4,70%
Earnings Growth (1Y) 27,58% Earnings Growth (3Y) 236,45%
Revenue Growth (5Y) -28,39% Earnings Growth (5Y) -52,04%
Profitability
Revenue (TTM) 1,74B Net Income (TTM) 150,97M
ROE 4,11% ROA 3,70%
Gross Margin 7,55% Operating Margin 7,55%
Net Margin 8,66% Free Cash Flow (TTM) 51,75M
ROIC 2,63% FCF Growth (3Y) -33,10%
Safety
Debt / Equity 0,02 Current Ratio 9,80
Interest Coverage 94,74 Dividend Yield 0,01%
Valuation
P/E Ratio 5,58 P/B Ratio 0,23
P/S Ratio 0,48 PEG Ratio 0,84
EV/EBITDA -0,11 Dividend Yield 0,01%
Market Cap 841,70M Enterprise Value -14,78M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,74B 1,91B 1,59B 2,34B 6,63B
Net Income 150,97M 118,34M 13,34M 157,10M 2,85B
EPS (Diluted) 0,06 0,05 0,01 0,06 1,12
Gross Profit 131,68M 777,96M 640,55M 950,91M 4,60B
Operating Income 131,68M 114,40M 35,95M 184,51M 3,72B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 4,08B 4,09B 4,20B 4,33B 5,08B
Total Liabilities 359,52M 414,68M 339,32M 429,22M 1,02B
Shareholders' Equity 3,70B 3,65B 3,84B 3,88B 4,03B
Total Debt 63,31M 82,54M 17,34M 83,55M 251,80M
Cash & Equivalents 919,79M 974,11M 1,27B 1,35B 2,56B
Current Assets 2,25B 2,48B 2,80B 2,86B 3,58B
Current Liabilities 229,99M 293,92M 213,72M 284,75M 825,29M

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#737 of 820
18
Value Defensive Investing (Benjamin Graham)
#153 of 708
48

Recente Activiteit

Ingestapt Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt Defensive Investing (Benjamin Graham)
Mar 24, 2026